Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'Optimising the management of initially localised kidney cancer - from screening to adjuvant therapy'


Professor Grant D StewartGrant Stewart is Professor of Surgical Oncology at the University of Cambridge, where he has a focus on developing and promoting surgery related clinical trials and translational research. As a urological surgeon, Grant has a specific interest in optimising management of patients with initially localised renal cancer, an area of great need within the disease, he provides all modes of treatment for kidney cancer, from major open surgery to robotic minimally invasive approaches. He is particularly interested in the concepts of early detection and screening for kidney cancer (Chief Investigator of the Yorkshire Kidney Screening Trial), optimised follow-up, as well as peri-surgical systemic therapy to optimise survival (i.e. NAXIVA, RAMPART and WIRE clinical trials). In order to make practice changing developments Professor Stewart has developed a range of interlinked clinical trials and translational research which are all underpinned by clinical excellence in managing renal cancer at Addenbrooke’s Hospital, Cambridge. To deliver on the above goals, Grant coordinates the Cambridge Renal Cancer Collaboration (CamRenCan) a group of over 40 clinicians, translational researchers and basic scientists across the Cambridge Biomedical Campus with a shared interest in renal cancer research. Professor Stewart is also Programme Lead for both Urological Malignancies and Integrated Cancer Medicine at CRUK Cambridge Centre. His research metrics are: £56 million research grant/clinical trial income and over 190 peer reviewed publications.

Professor Stewart moved to Cambridge in October 2015 from a post as Senior Lecturer in Urological Surgery at the University of Edinburgh where he led the Edinburgh Urological Cancer Group. Grant developed and co-directs the Scottish Collaboration On Translational Research into Renal Cell Cancer (SCOTRRCC), a Scotland-wide kidney cancer biorepository of 1200 patients with high quality clinical data linkage. 

Professor Stewart is Chair of the Scientific and Education Committee of The Urology Foundation, a member of the Clinical Expert Review Panel of Cancer Research UK, is a Trustee of Kidney Cancer UK, Section Editor of the British Journal of Urology International and member of Association of Academic European Urologists.


All members of the University and NHS clinical staff are welcome.

Spaces are limited within the lecture theatre due to COVID social distancing measures in the hospital. Please email Louise King if you would like to attend online or in person.